Your browser doesn't support javascript.
loading
Autoantibodies to killer cell immunoglobulin-like receptor 3DL1 in patients with systemic lupus erythematosus.
Doi, A; Kano, S; Asano, M; Takahashi, Y; Mimori, T; Mimori, A; Kaneko, H.
Affiliation
  • Doi A; Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kano S; Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Asano M; Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
  • Takahashi Y; Department of Tropical Medicine and Malaria, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mimori T; Division of Rheumatic Diseases, Hospital, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mimori A; Graduate School of Medical Science, Nagoya City University, Nagoya, Japan.
  • Kaneko H; Division of Rheumatic Diseases, Hospital, National Center for Global Health and Medicine, Tokyo, Japan.
Clin Exp Immunol ; 195(3): 358-363, 2019 03.
Article in En | MEDLINE | ID: mdl-30421793

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Receptors, KIR3DL1 / Lupus Erythematosus, Systemic Type of study: Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Immunol Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Receptors, KIR3DL1 / Lupus Erythematosus, Systemic Type of study: Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Immunol Year: 2019 Document type: Article Affiliation country: Country of publication: